We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

48 hedge funds and large institutions have $182M invested in T2 Biosystems, Inc in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

6% less funds holding

Funds holding: 5148 (-3)

8% less capital invested

Capital invested by funds: $198M → $182M (-$15.8M)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
48
Holders Change
-3
Holders Change %
-5.88%
% of All Funds
1.28%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
8
Increased
14
Reduced
6
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$41.6M +$442K +10 +1%
AC
2
Aisling Capital
New York
$27.9M
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$19.9M
Wellington Management Group
4
Wellington Management Group
Massachusetts
$16M -$442K -10 -3%
SM
5
Senvest Management
New York
$12.9M +$3.09M +70 +36%
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$10.8M
LIM
7
Lagoda Investment Management
New York
$10.6M +$5.97M +135 +171%
FVFI
8
Flagship Ventures Fund IV
Massachusetts
$7.31M +$6.54M +148 New
TM
9
Tiger Management
New York
$5.45M +$1.1M +25 +29%
Vanguard Group
10
Vanguard Group
Pennsylvania
$4.72M +$353K +8 +9%
GGHC
11
Gilder Gagnon Howe & Co
New York
$4.35M -$309K -7 -7%
EIM
12
Essex Investment Management
Massachusetts
$3.36M
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$3.33M -$1.15M -26 -28%
BFA
14
BlackRock Fund Advisors
California
$2.71M +$44.2K +1 +2%
BIT
15
BlackRock Institutional Trust
California
$1.94M -$265K -6 -13%
SM
16
Sabby Management
Florida
$1.43M -$751K -17 -37%
Northern Trust
17
Northern Trust
Illinois
$1.32M +$44.2K +1 +4%
State Street
18
State Street
Massachusetts
$927K +$177K +4 +27%
SIM
19
Spark Investment Management
New York
$722K
Bank of New York Mellon
20
Bank of New York Mellon
New York
$371K
WC
21
Woodstock Corp
Massachusetts
$368K
TCIM
22
TIAA CREF Investment Management
New York
$341K +$44.2K +1 +17%
BIM
23
BlackRock Investment Management
Delaware
$331K +$44.2K +1 +17%
UBS Group
24
UBS Group
Switzerland
$322K +$265K +6 +600%
TC
25
TFS Capital
Pennsylvania
$315K +$44.2K +1 +20%

TTOO Hedge Fund Activity: Q1 2016 in Review

48 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2016, worth a combined $182M — down 8% from $198M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of TTOO and 8 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 14 added.

The largest buyer was Lagoda Investment Management, adding an estimated $5.97M. The largest seller was Millennium Management, exiting entirely with an estimated $2.77M sold.

  • 48 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2016, down from 51 in Q4 2015.
  • Funds reported $182M of T2 Biosystems, Inc stock for Q1 2016, down 8% quarter-over-quarter.
  • 8 funds opened new T2 Biosystems, Inc positions in Q1 2016 and 9 closed out, a net change of -1 holder.
  • The largest T2 Biosystems, Inc buyer in Q1 2016 was Lagoda Investment Management, an estimated $5.97M added.
  • The largest T2 Biosystems, Inc seller in Q1 2016 was Millennium Management, an estimated $2.77M sold.

Based on aggregated 13F filings for Q1 2016.